Monte Rosa Therapeutics: Q2 Earnings Snapshot
BOSTON (AP) _ Monte Rosa Therapeutics Inc. (GLUE) on Thursday reported a loss of $26.5 million in its second quarter.
The Boston-based company said it had a loss of 57 cents per share.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 54 cents per share.